Alithea Genomics is a global leader in scalable transcriptomics solutions for screening applications. We work with pharma, biotech, and agrochemical clients to boost and de-risk their compound selection efforts.

Our high throughput and ultra-low-cost library preparation technologies (DRUG-seq) enable RNA-seq data to be generated from several thousand samples in a convenient and streamlined solution.

Our pipeline does not require RNA extraction and has been validated on several cell lines and organoid types. 

On the data analysis side, we provide default upstream, downstream, and QC analysis but we also provide bespoke solutions via our team of bioinformatic experts.

In addition to library preparation, sequencing, and data analysis, we provide end-to-end and very high-throughput cell culture, treatment, and imaging services (cell painting).